FindTrial
Sign In

The safety and efficacy of transluminal injection of foam sclerotherapy after endovenous thermal ablation in varicose veins with large trunk

The safety and efficacy of transluminal injection of foam sclerotherapy after endovenous thermal ablation in varicose veins with large trunk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067249
Enrollment
Unknown
Registered
2022-12-31
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins

Interventions

TLFS group :None
Non-TLFS group :None

Sponsors

Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with varicose veins treated by endovenous thermal ablation. 2. The diameter of the trunk of the great saphenous vein ranged from 10mm to 15mm.

Exclusion criteria

Exclusion criteria: 1. Preoperative history of deep vein thrombosis (DVT). 2. Combined with lower limb artery disease. 3. Liver and kidney failure. 4. Hardener allergies. 5. Incoagulation or hypercoagulability. 6. Complicated with varicose small saphenous veins. 7. No regular outpatient review one year after surgery.

Design outcomes

Primary

MeasureTime frame
Complete occlusion rate;—

Secondary

MeasureTime frame
Operation time;Number of incisions;Deep vein thrombosis occurred after operation;Thrombophlebitis;Skin burns;Paresthesia;Pain;Infection;—

Countries

China

Contacts

Public ContactHuang Kai

Sun Yat-sen Memorial Hospital of Sun Yat sen University

huangk@mail.sysu.edu.cn+86 188 2000 1023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026